Skip to main content
Clinical Trials/NL-OMON44800
NL-OMON44800
Recruiting
N/A

Sensory processing in autism and childhood epilepsy - SPACE-study

niversitair Medisch Centrum Utrecht0 sites120 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
autism spectrum disorders - autism
Sponsor
niversitair Medisch Centrum Utrecht
Enrollment
120
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Sponsor
niversitair Medisch Centrum Utrecht

Eligibility Criteria

Inclusion Criteria

  • Ability to comply with the protocol\-specified procedures for the duration of the study
  • IQ above 70
  • Written informed consent (and assent if appropriate to local laws and regulations),
  • In case of methylphenidate use, willingness to skip methylphenidate on the testing days
  • For epilepsy groups: Males and females aged 7\-12, Diagnosis of epilepsy and ASD symptoms (SRS50\+ or diagnosis according to ADOS, or probable/definite difference at SP\-NLor behavioral problems indicative of sensory processing problems (problems at school, irritability etc)
  • For ASD group: Males and females aged 7\-12, Diagnosis according to ADOS or given by psychiatrist
  • For control group: Males and females aged 7\-15, No psychiatric disorder present

Exclusion Criteria

  • Major visual or auditory impairment
  • Presence of severe medical disorder
  • Other (psychiater) disorders other than epilepsy or ASD

Outcomes

Primary Outcomes

Not specified

Similar Trials